Mercado mundial de fármacos antitusivos: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de medicamentos antitusivos

En los últimos años, se prevé que el mercado de los fármacos antitusivos crezca rápidamente durante el período de pronóstico. Los medicamentos antitusivos reducen la tos al disminuir la actividad de la tos y ofrecen alivio de la tos seca. Los antitusivos vienen en varias formas, incluidos los antitusivos de acción central, que incluyen derivados opioides, narcóticos, no opioides y otros. Los anestésicos locales son fármacos antitusivos que actúan localmente. La tos es un síntoma reflejo defensivo crucial para la salud, pero cuando dura un período prolongado de tiempo, las personas deben buscar ayuda médica. La tos afecta a más del 40% de la población mundial en un momento dado. La tos es causada más comúnmente por una infección del tracto respiratorio superior, aunque la tos también puede ser causada por enfermedades pulmonares como la enfermedad pulmonar obstructiva crónica (EPOC), la fibrosis pulmonar idiopática y el cáncer de pulmón.

Data Bridge Market Research analiza que el mercado mundial de medicamentos antitusivos, que fue de USD 1351,72 millones en 2022, se disparará hasta USD 1878,58 millones para 2030 y se espera que experimente una CAGR del 4,20% durante el período de pronóstico. Esto indica que el valor de mercado. Los "hospitales" dominan el segmento final del mercado de medicamentos antitusivos debido a la creciente conciencia sobre la medicación adecuada. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera de productos, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Market Definition

Cough suppressants, often known as antitussives, are drugs that prevent coughing. Although the specific mechanism of action is uncertain, antitussives are hypothesized to work by blocking a coordinating area for coughing in the brain stem, so breaking the cough reflex arc. Opioids are the source of many antitussives, including pholcodine, codeine, and dextromethorphan.

Antitussive Drugs Market Dynamics

Drivers

• Surging prevalence of cough

Cough is estimated to be a major element driving demand for antitussive drugs, which will propel the market forward. Cough is the most common reason for visits to primary care physicians worldwide, accounting for roughly 8% of all consultations, according to data published by the National Center for Biotechnology Information in 2014. According to the same source, the global annual prevalence of cough in the general population is estimated to be between 10% and 33%.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of antitussive drugs market is the rising healthcare expenditure which helps in improving its infrastructure.

• Rising geriatric population

The surging number of geriatric population will propel the market's growth rate during the forecast period of 2022-2029. As per the World Ageing 2020 research, the world's population will be roughly 727 million people aged 65 and up in 2020. In 2050, the number of elderly people is expected to increase to 1.5 billion. The geriatric population is more prone to chronic ailments, which is anticipated to enhance the market's growth rate.

Opportunity

• Innovation and Drug Development:

Ongoing research and development in the pharmaceutical industry are leading to the discovery of novel antitussive compounds and formulations. The introduction of innovative drugs with improved efficacy and fewer side effects provides opportunities for pharmaceutical companies to capture market share and address unmet medical needs.

Restraint/Challenge

• Limited Efficacy and Side Effects

One significant restraint in the antitussive drugs market is the limited efficacy of many available medications, especially for chronic cough conditions. Cough is a natural reflex that helps clear the airways, and suppressing it entirely can lead to complications. Some antitussive drugs might not effectively address the underlying cause of the cough, leading to symptomatic relief without treating the root issue.

In addition, some antitussive medications can cause side effects such as drowsiness, constipation, dizziness, and nausea. These side effects can affect the patient's quality of life, leading to non-compliance or discontinuation of the medication. Patients, especially those with pre-existing health conditions or those taking multiple medications, might be hesitant to use antitussive drugs due to potential interactions and adverse effects. Furthermore, the overuse or misuse of antitussive medications, particularly those containing opioids, has raised concerns about addiction and abuse. Healthcare providers need to carefully weigh the benefits against the risks when prescribing these medications, leading to cautious use and limited prescription, acting as a restraint in the market. Complex regulatory processes and the need for compliance with diverse guidelines in different countries pose challenges for sponsors, leading to delays and increased costs.

This antitussive drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the antitussive drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In September 2021, Sun Pharmaceutical Industries Ltd. announced the launch of a novel formulation in cough management - Chericof 12 (Dextromethorphan Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg) in India. Chericof 12, India's first prescription cough syrup that provides relief for up to 12 hours, is made with Polistirex technology for long-term medication release. Chericof 12 is only for individuals who are six years old or older

Global Antitussive Drugs Market Scope

The antitussive drugs market is segmented on the basis of drug, drug class, indication, product type, age group, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug

• Benzonatate
• Dextromethorphan

Drug Class

• Centrally Acting Drugs
  • Opioids
  • Non-opioids
• Peripherally Acting Drugs
  • Phenoxdiazine
  • Others
• Others

Route of Administration

• Oral
• Inhalational
• Others

Dosage Form

• Syrup
• Tablet
• Others

Indication

• Cold Symptoms
• Pain
• Cough
• Others

Product Type

• Over-the-counter (OTC)
• Prescription Drug

Age Group

• Pediatric
• Adult
• Geriatric

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Global Antitussive Drugs Market Regional Analysis/Insights

Clinical trials market is analyzed and market size insights and trends are provided by country, drug, drug class, indication, product type, age group, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the antitussive drugs market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, rest of Middle East & Africa.

North America is expected to dominate the antitussive drugs market due to the use of the growing geriatric population and over use of unhealthy food in this region. In addition, the surging number of initiatives taken by the pharmaceutical organizations to generate novel formulation mainly for pediatric population and rising healthcare expenditure will further propel the market's growth rate in this region.

Asia-Pacific is expected to grow during the forecast period due to surging government initiatives to spread awareness and increasing the geriatric population in this region. Also, the development of healthcare infrastructure will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Crecimiento de la infraestructura de salud Base instalada y penetración de nuevas tecnologías

El mercado de medicamentos antitusivos también le proporciona un análisis detallado del mercado para cada país: crecimiento del gasto sanitario en equipos de capital, base instalada de diferentes tipos de productos para el mercado de medicamentos antitusivos, impacto de la tecnología mediante curvas de línea de vida y cambios en los escenarios regulatorios de la atención médica y su impacto en el mercado de medicamentos antitusivos. Los datos están disponibles para el período histórico 2010-2020.

Análisis del panorama competitivo y de la cuota de mercado de los fármacos antitusivos

El panorama competitivo del mercado de medicamentos antitusivos proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos, el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de medicamentos antitusivos.

Algunos de los principales actores que operan en el mercado de medicamentos antitusivos son:

• F. Hoffmann-La Roche Ltd. (Suiza)
• Mylan NV (Estados Unidos)
• Industrias farmacéuticas Teva Ltd. (Israel)
• Sanofi (Francia), Pfizer Inc. (EE. UU.)
• GlaxoSmithKline plc (Reino Unido)
• Novartis AG (Suiza)
• Industrias farmacéuticas Sun Ltd. (India)
• Amneal Pharmaceuticals LLC. (Estados Unidos)
• Zydus Cadila (India)
• Aurobindo Pharma (India)
• Cipla Inc. (Estados Unidos)
• Hikma Pharmaceuticals PLC (Reino Unido)
• AstraZeneca (Reino Unido)
• Johnson & Johnson Private Limited (Estados Unidos)
• Intas Pharmaceuticals Ltd. (India)
• 3M (Estados Unidos)
• Bayer AG (Alemania)
• Laboratorios Ipca Ltd. (India)
• Unique Pharmaceuticals Limited (India)
• Aceto (Estados Unidos) 

SKU-53928